Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma

INTRODUCTON: We wanted to identify the prognostic factors for overall survival (OS) in Chinese patients with metastatic renal cell carcinoma (mRCC) treated with first-line targeted therapy (sorafenib or sunitinib). METHODS: We retrospectively reviewed clinical data from 119 mRCC patients administere...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can Urol Assoc J
Autors principals: Zhao, Juping, Huang, Xin, Sun, Fukang, Ma, Renyi, Wang, Haofei, Shao, Kun, Zhu, Yu, Zhou, Wenlong, Xu, Zhaoping, Shen, Zhoujun
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2014
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250247/
https://ncbi.nlm.nih.gov/pubmed/25485010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.2096
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars